This is the authors' abstract. We don't add key points for this paper.
HMGB1 is involved in both early and later stages after TBI. Targeting HMGB1 signaling may be a promising therapeutic approach for the treatment of TBI.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: